Glycans in Diseases and Therapeutics


Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited


  • Glycomedicine
  • Transfusion medicine
  • Congenital disorders of glycosylation (CDG)
  • Cancer biomarkers
  • Cardiovascular diseases
  • Cardiac arrest
  • Cancer associated coagulopathies

Related Conference of Glycans in Diseases and Therapeutics

February 22-23, 2023

International Bio Summit and Expo

London, UK
April 17-18, 2023

13th World Glycobiology Congress

Rome, Italy
June 19-20, 2023

5th International Conference on Biochemistry

London, UK
June 19-20, 2023

5th International Conference on Nucleic Acids

London, UK
June 27-28, 2023

13th Annual Summit on Advanced Bionics

Vienna, Austria
September 21-22, 2023

19th World Congress on Structural Biology

Paris, France
September 21-22, 2023

14th International Conference on Biofuels and Bioenergy

Toronto, Canada
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy
November 01-02, 2023

19th International Conference on Metabolomics

Rome, Italy

Glycans in Diseases and Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in